Genomma Lab Internacional, S.A.B. de C.V. reported that it has submitted a non-binding proposal to acquire all of the outstanding shares of Prestige Brands Holdings Inc - PBH - common stock for $16.60 dollars per share in cash. Threshold Pharmaceuticals Inc - THLD - reported Positive Phase 2b Clinical Trial Results of TH-302 in Patients With Pancreatic Cancer. Crown Equity Holdings Inc - CRWE - reported that its subsidiary Crown Tele Services Inc. has entered into 2 letters of intent, one with BBN Solutions and the other with MVOX AG. CRWE also reported that it has launched two new online service companies: CRWE Real Estate and and CRWE Direct. ********************************* THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://www.crwenewswire.com/disclaimer)

• Added by: karmastock
• Date added: 21/02/12
• Video Duration: 01:13
• Category: News
• Number of views:360
• Tags: Crown Equity Holdings, CRWE, Genomma Lab, Nasdaq:THLD, NYSE:PBH, otc:crwe, Prestige Brands, THLD, Threshold Pharmaceuticals (PBH, CRWE, THLD) CRWENewswire Stocks In Action



Post a Comment

To add a comment, please fill out the box below and click on the submit button. Comment:

There are currently no comments for this video